Coronavirus: Russia agrees to produce Sputnik V vaccine in India
dw.com
2020-11-27
© Provided by dw.com
Russia's sovereign wealth fund and the Indian pharmaceutical company Hetero agreed to produce more than 100 million doses per year in India of the Sputnik V vaccine, according to a statement on Friday.
The Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally, plans to start production at the beginning of 2021.
With final-phase trials ongoing, Indian drugmaker Dr Reddy's Laboratories Ltd. said it expected late-stage trials to be finalized as soon as March 2021.
Author: Richard Connor
dw.com
![image beacon](https://web.vortex.data.msn.com/collect/v1/t.gif?name=%27Ms.Webi.PageView%27&ver=%272.1%27&appId=%27JS%3AMSN%27&ext-app-env=%27prod%27&ext-javascript-libver=%274.0.0-beta-10%27&ext-user-localId=%27t%3A1E1554ED03F46010140A5B2F02E661F9%27&*baseType=%27Ms.Content.PageView%27&*isJs=False&*title=%27%27&*isLoggedIn=False&*isManual=True&*serverImpressionGuid=%27dcb31fad-a122-4f62-9e51-205af61a79f2%27&-ver=%271.0%27&-impressionGuid=%27dcb31fad-a122-4f62-9e51-205af61a79f2%27&-pageName=%27article%27&-uri=%27https%253A%252F%252Fwww.msn.com%252Fen-za%252Fnews%252Fother%252Fcoronavirus-russia-agrees-to-produce-sputnik-v-vaccine-in-india%252Far-BB1bpbSE%253Fli%253DBBqfWMK%27&-referrerUri=%27%27&-pageTags=%27{"pg.t"%3A"article"%2C"pg.p"%3A"prime"%2C"pg.c"%3A""%2C"ex"%3A""%2C"rid"%3A"dcb31fada1224f629e51205af61a79f2"%2C"clid"%3A"1E1554ED03F46010140A5B2F02E661F9"%2C"clidType"%3A"muid"%2C"di"%3A"2230"%2C"partner"%3A"dw.com"%2C"publcat"%3A"Deutsche%2BWelle"%2C"cvs"%3A"Browser"%2C"subcvs"%3A"news"%2C"entityId"%3A"BB1bpbSE"%2C"entitySrc"%3A"ar"%2C"provid"%3A"AA2hbqb"%2C"dpt"%3A"newsother"%2C"sdpt"%3A""%2C"ar"%3A"0"%2C"dgk"%3A"downlevel.pc"%2C"imd"%3A"0"%2C"parentId"%3A"BBqfWMK"%2C"pgIdx"%3A""%2C"pgTot"%3A""%2C"anoncknm"%3A""%2C"afd"%3A""%2C"issso"%3A"0"%2C"aadState"%3A"0"}%27&-behavior=0&-market=%27en-za%27){kind=small}